Skip to content

Impact of Clinical Pharmacist on the Quality and Cost of the Therapeutic Management of Patients in Two Medical Services of a Teaching Hospital

Impact of Clinical Pharmacist on the Quality and Cost of the Therapeutic Management of Patients in Two Medical Services of a Teaching Hospital

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02887001
Acronym
ImpactPharma
Enrollment
500
Registered
2016-09-01
Start date
2011-06-01
Completion date
2012-07-01
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Admitted to Infectiology or Internal Medicine Wards

Keywords

cost study, clinical pharmacist

Brief summary

Incomplete information or poorly communicated to the transitional stages of the patient's drug therapy hospitalized cause medication errors. These steps are the admission, transfer within the institution and hospital discharge to home or another institution. The adequacy of the prescription recommendations of good practice is not always optimal. The cost of taking drug therapy and iatrogenic risks preventable drug-related weighs more and more heavily in health spending and in the prolongation of hospitalization or re hospitalization. Clinical pharmacy widely practiced in the Anglo-Saxon countries has demonstrated its effectiveness on these three themes; it seems appropriate to assess this practice in the environment of the French health system.

Interventions

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* patients admitted in in infectious and tropical diseases unit or the internal medicine unit

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
Number of prescriptions11 weeks

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026